# Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC

> **NCT00767377** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 163 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** EOF5

## Key facts

- **NCT ID:** NCT00767377
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2012-07
- **Final completion:** 2013-03
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2013-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767377, "Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00767377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*